Publications by authors named "Miklos Acs"

Claim this Profile
I
Intensive care scores predict outcomes in patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Julia Wimmer, Miklos Acs, Gyula Bohus, Patricia Hauer, Veronika Müller

Front Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic resection for ovarian cancer in Germany: a nationwide epidemiological study based on DRG (diagnosis-related groups) data (2020-2024).
Miklos Acs, Veronika Müller, Sandra Gebhard, Benedikt J Wagner, Niklas Bogovic

World J Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced recovery for cytoreductive surgery and hyperthermic intraperitoneal Chemotherapy: An international survey to assess acceptance and feasibility.
Amaniel Kefleyesus, Naoual Bakrin, Vahan Kepenekian, Chloé Gerbaud-Coulas, Anne Li, Miklos Acs

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers.
Maximilian Eckert, Michael Gerken, Jens M Werner, Sebastian Blaj, Ferdinand Füsi, Miklos Acs

Pleura Peritoneum· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the tail of the pancreas always tumor-infiltrated when macroscopically affected during cytoreductive surgery? A clinicopathological study and experience from a high-volume center.
Miklos Acs, Jozef Zustin, Niklas Bogovic, Pompiliu Piso, Sebastian Blaj

World J Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of Postoperative Complications in Pancreatic Surgery by Standardizing Perioperative Management: An Observational Cohort Study.
Jonas Herzberg, Tim Strate, Miklos Acs, Pompiliu Piso, Salman Yousuf Guraya

Visc Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis.
Ivan Panczel, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study.
Jonas Herzberg, Miklos Acs, Salman Yousuf Guraya, Hans Jürgen Schlitt, Human Honarpisheh

Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
Miklos Acs, Pompiliu Piso, Gabriel Glockzin

Curr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Miklos Acs, Maximilian Babucke, Maximilian Jusufi, Zsolt Kaposztas, Przemyslaw Slowik

Innov Surg Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Treatment and Outcome of Ovarian Cancer Patients With Liver Metastases: Experience of a Tertiary Hepatic and Peritoneal Surface Malignancy Center.
Miklos Acs, Zoltan Herold, Lea Neumann, Przemyslaw Slowik, Katja Evert

Anticancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Akash Kartik, Catharina Müller, Miklos Acs, Pompiliu Piso, Patrick Starlinger

Pleura Peritoneum· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.
Andras Jozsef Barna, Zoltan Herold, Miklos Acs, Sandor Bazsa, Jozsef Gajdacsi

Int J Mol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases.
Heinrich Steinhoff, Miklos Acs, Sebastian Blaj, Magdolna Dank, Magdolna Herold

World J Gastroenterol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Miklos Acs, Michael Gerken, Jozef Zustin, Sebastian Blaj, Sabina Isgandarova

J Surg Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers.
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Roland Kodacsi, Miklos Acs

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS.
Miklos Acs, Michael Gerken, Vanessa Schmitt, Pompiliu Piso, Alfred Königsrainer

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Miklos Acs, Michael Gerken, Ivana Gajic, Max Mayr, Jozef Zustin

Langenbecks Arch Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts.
Zoltan Herold, Miklos Acs, Attila Marcell Szasz, Katalin Olasz, Jana Hussong

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Alaedin Rajha, Pompiliu Piso, Laszlo Halmy, Ivan Panczel, Dan-Sebastian Nedelcut, Miklos Acs

Anticancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
Miklos Acs, Zoltan Herold, Attila Marcell Szasz, Max Mayr, Sebastian Häusler

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection Criteria for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Special Emphasis on Laparoscopy as an Efficient Tool.
Miklos Acs, Aydin Dadras, Sebastian Blaj, Hubert Leebmann, Pompiliu Piso

In Vivo· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre.
Miklos Acs, Laszlo Halmy, Sabina Isgandarova, Sebastian Blaj, Michael Gerken

Anticancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review.
Miklos Acs, Pompiliu Piso, Sonia Prader

Anticancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.
Miklos Acs, Hubert Leebmann, Sebastian Häusler, Philipp Harter, Pompiliu Piso

In Vivo· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis